Skip to content

Screening of metabolites associated with hepatic encephalopathy and study of mechanisms

Screening of metabolites associated with hepatic encephalopathy and study of mechanisms

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2400089932
Enrollment
Unknown
Registered
2024-09-19
Start date
2024-10-08
Completion date
Unknown
Last updated
2024-09-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatic encephalopathy

Interventions

Control group:NA
Cirrhosis group:NA
Hepatic encephalopathy:NA

Sponsors

Sichuan Provincial People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1: Inclusion criteria for the normal control group: (1) 80 years = age = 18 years; (2) not suffering from any underlying diseases, such as hypertension, diabetes, etc.; (3) not taking any medication for a long time, and drinking = 50 g/day; (4) not pregnant or in the breastfeeding period. 2: Inclusion criteria for patients with cirrhosis: (1) 80 years = age = 18 years; (2) those with a confirmed diagnosis of cirrhosis; and (3) those who were in the compensated stage of cirrhosis, with Child-Pugh class A, and who may have mild esophageal varices but no complications such as ascites or hepatic encephalopathy. 3: Inclusion criteria for patients with hepatic encephalopathy: (1) 80 years = age = 18 years; (2) patients with clinically diagnosed encephalopathy; and (3) no cerebral neurologic disease.

Exclusion criteria

Exclusion criteria: 1: Exclusion criteria for patients with cirrhosis: (1) those with comorbid metabolism-related disorders such as hypertension, diabetes mellitus, and thyroid disorders 2: those with a history of gastrointestinal bleeding in the last 2 weeks and with a hemoglobin concentration of <90 g/L 3: a score of <25 on the mini mental status examination(MMSE) 4: those who are pregnant or in the process of breastfeeding 5: those who are not able to cooperate with the study in terms of mental status, suffering from psychiatric disorders, lack of self-control, and inability to express themselves explicitly 6: those who are deemed by the investigators to be unsuitable for the clinical trial for other reasons 7: those who are unable to read or write the

Design outcomes

Primary

MeasureTime frame
Blood untargeted metabolomics;

Countries

China

Contacts

Public ContactPeng Li

Sichuan Provincial People's Hospital

lipengmazui@163.com+86 136 6816 9590

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026